INVO Bioscience, Inc. — Form D

INVO Bioscience, Inc. of SARASOTA, FL, a company, filed a Form D exempt-offering notice with the SEC on 2023-04-06. The offering totals $3.0M, of which $3.0M was reported sold. Industry: Other Health Care.

Offering

Issuer

Officers, directors & promoters (21)

NameRoleLocation
Trent DavisDirectorFRISCO, TX
Rebecca MessinaDirectorSeal Beach, CA
Barbara RyanDirectorSarasota, FL
Steven ShumDirectorSarasota, FL
Matthew SzotDirectorPonte Vedra, FL
Michael CampbellExecutive OfficerNewport Beach, CA
Andrea GorenExecutive OfficerSarasota, FL
Steven ShumExecutive OfficerSarasota, FL
Jeffrey SegalDirectorSarasota, FL
Debra T HoopesExecutive OfficerSarasota, FL
Kevin DoodyDirectorSarasota, FL
Steven T ShumDirectorMedford, MA
Robert J BowdringDirectorMedford, MA
Robert J BowdringExecutive OfficerMedford, MA
Kevin J DoodyDirectorMedford, MA
Kathleen T KarloffDirectorMedford, MA
Kathleen T KarloffExecutive OfficerMedford, MA
Michael J CampbellDirectorSandy Springs, GA
Michael J CampbellExecutive OfficerSandy Springs, GA
Claude J RanouxExecutive OfficerBeverly, MA
Kathleen J KarloffExecutive OfficerBeverly, MA

Other filings by this issuer (7)

FiledFormOfferingSold
2023-03-06D/A$500K$500K
2023-02-17D$500K$300K
2023-01-11D$3.5M$275K
2020-07-15D/A$3.5M$3.5M
2020-05-28D$3.5M$2.1M
2018-01-24D$1.5M$15K
2009-10-14D$545K$545K

More